Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Dermatology
/ Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Changing Landscape of Biological Therapies for Psoriasis: Promising Efficacy of Interleukin-17 (IL-17) and IL-2 Pathway Inhibitors
Complimentary
Categories:
Activity Type
,
ANCC
,
CME
,
Credit Type
,
Dermatology
,
Endocrinology
,
Family Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Pediatrics
,
Physician
,
Physician Assistant
,
Profession
Related products
New Paradigms in the Management of Hereditary Transthyretin Amyloidosis Mixed Phenotype (ATTRv): ATTRv-CM and ATTRv-PN
Read more
Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Read more
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Read more
MGD-Associated Dry Eye Disease: Pathophysiology, Current and Emerging Therapies for Improved Outcomes
Read more
Scroll To Top